Recruiting A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations NCT05503797 Conditions Adenocarcinoma, Adnexal Diseases, Biliary Tract Diseases, +52 more Locations Precision NextGen Oncology & Research Center — Beverly Hills, California, United States UCSF Helen Diller Family Comprehensive Cancer Center — San Francisco, California, United States University of California Los Angeles Rheumatology — Westwood, Los Angeles, California, United States Norwalk Hospital — Norwalk, Connecticut, United States View all 70 locations View more locations Show fewer locations Loading locations... View Trial Details
